|
ABBV
|
AbbVie Inc.
|
US
|
NYSE
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ACRX
|
AcelRx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AERI
|
Aerie Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ASRT
|
Assertio Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ATXI
|
Avenue Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AVTE
|
Aerovate Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BHVN
|
Biohaven Pharmaceutical Holding Company Ltd.
|
US
|
NYSE
|
|
CLVS
|
Clovis Oncology, Inc.
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
US
|
NASDAQ
|
|
CTIC
|
Cell Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DRRX
|
DURECT Corporation
|
US
|
NASDAQ
|
|
DRUG
|
Bright Minds Biosciences Inc.
|
US
|
NASDAQ
|
|
EBLU
|
Ecofin Global Water ESG Fund
|
US
|
AMEX
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
INCY
|
Incyte Corporation
|
US
|
NASDAQ
|
|
IXHL
|
Incannex Healthcare Limited
|
US
|
NASDAQ
|